Last update 08 May 2025

TQH3910

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases
Active Indication
Dermatitis, Atopic
Inactive Indication
Rheumatoid Arthritis
Originator Organization
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Active Organization
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with TQH3910
CTR20222414
/ TerminatedPhase 2
评价TQH3910片治疗甲氨蝶呤反应不佳的中重度活动性类风湿关节炎患者的有效性、安全性的随机、双盲、平行对照、多中心II期临床试验
[Translation] A randomized, double-blind, parallel-controlled, multicenter phase II clinical trial to evaluate the efficacy and safety of TQH3910 tablets in the treatment of moderately to severely active rheumatoid arthritis patients who have an inadequate response to methotrexate
ChiCTR2200062076
/ SuspendedPhase 1IIT
The safety, tolerability and pharmacokinetics of single and multiple-dose TQH3910 tablets in healthy adult subjects: a phase I clinical trial
CTR20221197
/ TerminatedPhase 1
TQH3910片在健康成人受试者中单次和多次给药的安全性、耐受性、药代动力学特征的Ⅰ期临床试验。
[Translation] A Phase I clinical trial to investigate the safety, tolerability, and pharmacokinetic characteristics of single and multiple doses of TQH3910 tablets in healthy adult subjects.
100 Clinical Results associated with TQH3910
Login to view more data
100 Translational Medicine associated with TQH3910
Login to view more data
100 Patents (Medical) associated with TQH3910
Login to view more data
100 Deals associated with TQH3910
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dermatitis, AtopicIND Approval
China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
24 Mar 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free